Claire Mercier
About
In The Last Decade
Claire Mercier
20 papers receiving 791 citations
Peers
Comparison fields: 5 of 101
- Oncology 378
- Molecular Biology 254
- Pediatrics, Perinatology and Child Health 196
- Immunology 144
- Microbiology 126
Countries citing papers authored by Claire Mercier
This map shows the geographic impact of Claire Mercier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claire Mercier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claire Mercier more than expected).
Fields of papers citing papers by Claire Mercier
This network shows the impact of papers produced by Claire Mercier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claire Mercier. The network helps show where Claire Mercier may publish in the future.
Co-authorship network of co-authors of Claire Mercier
This figure shows the co-authorship network connecting the top 25 collaborators of Claire Mercier. A scholar is included among the top collaborators of Claire Mercier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claire Mercier. Claire Mercier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 1 | |
| 5 | 0 | |
| 6 | 1 | |
| 7 | 25 | |
| 8 | 54 | |
| 9 | 164 | |
| 10 | 73 | |
| 11 | 24 | |
| 12 | 24 | |
| 13 | 41 | |
| 14 | 69 | |
| 15 | 12 | |
| 16 | 3 | |
| 17 | 11 | |
| 18 | 4 | |
| 19 | 4 | |
| 20 | [Peptide alkaloids of spurred rye and their semisynthetic derivatives. III. Ergot in therapeutics]. | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.